Tag Archives: Price

For Organovo Holdings, Slow Uptake Of Toxicity Products Now Reflects In The Price

For Organovo Holdings, Slow Uptake Of Toxicity Products Now Reflects In The Price
The note I wrote in May on Organovo Holdings (NYSEMKT:ONVO) was optimistic because of the fact that Organovo’s technology could help drug developers save billions of dollars in R&D spending. But I was also cautious because Organovo will only be a success …
Read more on Seeking Alpha

Deutsche Bank AG Lowers Expedia Inc. (EXPE) Price Target to $138.00

Deutsche Bank AG Lowers Expedia Inc. (EXPE) Price Target to 8.00
Expedia Inc. (NASDAQ:EXPE) had its target price dropped by investment analysts at Deutsche Bank AG from $ 142.00 to $ 138.00 in a note issued to investors on Friday. The brokerage presently has a “buy” rating on the online travel company’s stock.
Read more on Zolmax News

Deutsche Bank AG Lowers Expedia Inc. (EXPE) Price Target to $138.00

Deutsche Bank AG Lowers Expedia Inc. (EXPE) Price Target to 8.00
Expedia Inc. (NASDAQ:EXPE) had its target price dropped by investment analysts at Deutsche Bank AG from $ 142.00 to $ 138.00 in a note issued to investors on Friday. The brokerage presently has a “buy” rating on the online travel company’s stock.
Read more on Zolmax News